Phio Pharmaceuticals
PHIO
#10949
Rank
C$14.16 M
Marketcap
C$1.19
Share price
4.82%
Change (1 day)
-45.54%
Change (1 year)

Earnings for Phio Pharmaceuticals (PHIO)

Earnings in 2026 (TTM): -C$18.03 Million

According to Phio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$12.28 Million a decrease over its 2024 earnings that were of -C$10.1 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Phio Pharmaceuticals from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$18.03 Million46.79%
2025 -C$12.28 Million21.65%
2024 -C$10.1 Million-33.96%
2023 -C$15.28 Million-5.7%
2022 -C$16.21 Million-13.6%
2021 -C$18.76 Million51.09%
2020 -C$12.42 Million-1.28%
2019 -C$12.58 Million21.03%
2018 -C$10.39 Million-53.1%
2017 -C$22.16 Million74.49%
2016 -C$12.7 Million-12.02%
2015 -C$14.43 Million16.17%
2014 -C$12.43 Million-57.95%
2013 -C$29.54 Million62.45%
2012 -C$18.19 Million0.87%
2011 -C$18.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-C$0.12 Billion 518.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-C$25.63 Million 40.70%๐Ÿ‡บ๐Ÿ‡ธ USA